Antimicrobial resistance in Salmonella enterica serovar Enteritidis in Morocco

Farida Ohmani1, Khadija Khedid, Saad Britel

  • 1Laboratory of Medical Bacteriology, National Institute of Hygiene 27, Avenue Ibn Batouta, BP 769, Rabat, Morocco. farida.ohmani@gmail.com

Abstract

Insights

Salmonella Enteritidis in Morocco shows low overall antimicrobial resistance. However, resistance to nalidixic acid is common, with many resistant strains also showing reduced susceptibility to ciprofloxacin.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Salmonella enterica serovar Enteritidis is a significant cause of human gastrointestinal infections globally.
  • Understanding antimicrobial resistance patterns is crucial for effective treatment and control.

Purpose of the Study:

  • To determine the antimicrobial susceptibilities of Salmonella Enteritidis isolates from human sources in Morocco.
  • To assess resistance trends between 2000 and 2008.

Main Methods:

  • Disk diffusion method was used to test susceptibility to seven antibiotics.
  • Minimal inhibitory concentration (MIC) of ciprofloxacin was determined for nalidixic acid-resistant isolates using E-test strips.

Main Results:

  • 42% of isolates exhibited resistance to at least one antimicrobial agent.
  • Nalidixic acid resistance was most prevalent (36%), followed by ampicillin (5%), tetracycline (4%), and trimethoprim/sulfamethoxazole (1%).
  • Of the nalidixic acid-resistant isolates, 76% showed reduced susceptibility to ciprofloxacin.

Conclusions:

  • While overall resistance rates are low, nalidixic acid resistance in Salmonella Enteritidis is a significant concern in Morocco.
  • Continuous surveillance of antibiotic resistance is essential for public health interventions.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...